Parvovirus B19 DNA, Quantitative

Last Modified: 3/22/2022 10:44:56 AM


Medical Necessity Documentation:  
Client Notes:  
Patient Preparation:  
Specimen Requirements:

1.0 mL Plasma from a Lavender Top Tube - EDTA in a Plastic Vial
Collection Instructions:  
Minimum Volume: 0.3 mL Plasma
Transport & Storage: Temperature/Stability: 48 hours Ambient
7 days Refrigerated
30 days Frozen - No Freeze/Thaw cycles
Rejection Criteria: Frozen Heparinized specimens
Reference Range: Parvovirus B19 DNA QN Real time PCR: Not Detected copies/mL
Parvovirus B19 DNA QN Real time PCR: Log copies/mL
Critical Ranges:  
Test Comments:  
Methodology: Real-Time Polymerase Chain Reaction (RT-PCR)
Clinical Significance:

Parvovirus B19 infection has a wide variety of disease manifestations, including Fifth disease, transient aplastic crisis, persistent anemia and congenital hydrops fetalis. Quantification of parvovirus B19 genomic DNA is based upon Real-Time PCR amplification and detection. The quantitative range of this assay is 100–100,000,000 copies/mL.
Documentation:  
Custom Panel: No

PRODUCTION SCHEDULE

Turn Around Time: 1 to 2 days
Days Performed: Sunday, Monday, Tuesday, Wednesday, Thursday, Friday, Saturday
Sites Performed: Quest - Chantilly
PHL Test Code: MSOT
EPIC Test Code: MISC
Send Out Test Code: 19724
Alternate Test Names: Parvovirus B19 DNA, Quantitative, Real-Time PCR
Included Tests:  
CPT Coding: 87799

Go back to the top of the page.